Sohinolol

Sohinolol
Nazivi
IUPAC naziv
5-[3-(tert-Butilamino)-2-hidroksipropoksi]-3,4-dihidro-1H-izohinolin-2-karbaldehid
Identifikacija
3D model (Jmol)
ChemSpider
ECHA InfoCard 100.057.113
UNII
  • CC(C)(C)NCC(COC1=CC=CC2=C1CCN(C2)C=O)O
  • CC(C)(C)NCC(COc1cccc2c1CCN(C2)C=O)O
Svojstva
C17H26N2O3
Molarna masa 306,41 g·mol−1
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa).
Reference infokutije

Sohinolol je antagonist beta adrenergičkog receptora.[3]

Reference

[уреди | уреди извор]
  1. ^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003.  уреди
  2. ^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1. 
  3. ^ Gries, J; Unger, L; Einig, H; Friedrich, L; Hofmann, HP; Kreiskott, H; Lehmann, HD; Von Philipsborn, G; Wuppermann, D; Zimmermann, F (1988). „Pharmacological characterization of the new highly potent beta-adrenergic receptor blocker soquinolol”. Arzneimittel-Forschung. 38 (9): 1271—9. PMID 2906243.